axicabtagene ciloleucel
gilead
['axi-cel', 'lymsm', 'lymphoma', 'zuma-7']
#eha2022 | presented a subgroup analysis of zuma-7. second line axi-cel vs soc was associated with superior efs (hr, 0.276, p&lt;0.0001), and higher cr rates (75% vs 33%). grade 3 teaes occurred in 94% and 82% of axi-cel and soc pts, respectively #lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm